FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like AbbVie, J&J Withdraw Accelerated Approval of Imbruvica for Certain Blood Cancers April 7, 2023 Robert Califf Sounds Alarm if User Fees Aren’t Reauthorized Quickly July 12, 2022 Illumina to Appeal FTC’s Order to Divest Liquid Biopsy Maker Grail April 3, 2023